Complete financial analysis of JMDC Inc. (4483.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of JMDC Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Hunan Huamin Holdings Co., Ltd. (300345.SZ) Income Statement Analysis – Financial Results
- RPSG Ventures Limited (RPSGVENT.NS) Income Statement Analysis – Financial Results
- Microsaic Systems plc (MSYS.L) Income Statement Analysis – Financial Results
- Nova Vision Acquisition Corporation (NOVVW) Income Statement Analysis – Financial Results
- Conagra Brands, Inc. (0I2P.L) Income Statement Analysis – Financial Results
JMDC Inc. (4483.T)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.jmdc.co.jp
About JMDC Inc.
JMDC Inc. provides medical statistics data services in Japan. The company operates through three segments: Healthcare-Big Data, Telemedicine, and Dispensing Pharmacy Support. It offers medical field big data services; life insurance field big data services; support services for health insurance associations and local government health services; health data platform; and medical institution support services. The company also provides remote image interpretation matching services and ASP services for remote image interpretation system; and develops and sells business systems for dispensing pharmacies. It serves health insurance unions, pharmaceutical companies, life and non-life insurance companies, research institutions, etc. The company was incorporated in 2002 and is headquartered in Tokyo, Japan.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|---|
Revenue | 32.38B | 27.81B | 21.81B | 16.77B | 12.16B | 10.06B | 3.02B |
Cost of Revenue | 13.13B | 11.95B | 9.23B | 7.15B | 5.53B | 4.63B | 1.33B |
Gross Profit | 19.25B | 15.86B | 12.59B | 9.62B | 6.63B | 5.43B | 1.69B |
Gross Profit Ratio | 59.46% | 57.03% | 57.71% | 57.35% | 54.51% | 53.97% | 55.92% |
Research & Development | 184.00M | 158.00M | 201.00M | 206.00M | 206.00M | 300.00M | 37.00M |
General & Administrative | 12.02B | 10.16B | 7.85B | 5.92B | 4.27B | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 286.00M | 218.00M | 151.00M | 126.00M | 0.00 | 0.00 |
SG&A | 12.02B | 10.16B | 7.85B | 5.92B | 4.27B | 3.78B | 980.00M |
Other Expenses | 0.00 | 0.00 | -59.00M | 3.00M | 140.00M | 180.00M | 7.00M |
Operating Expenses | 12.25B | 9.93B | 7.79B | 5.92B | 4.41B | 180.00M | 7.00M |
Cost & Expenses | 25.38B | 21.88B | 17.01B | 13.08B | 9.94B | 4.81B | 1.34B |
Interest Income | 16.00M | 38.00M | 46.00M | 34.00M | 36.00M | 60.00M | 0.00 |
Interest Expense | 114.00M | 88.00M | 62.00M | 93.00M | 37.00M | 60.00M | 23.00M |
Depreciation & Amortization | 2.24B | 2.02B | 1.69B | 1.17B | 889.00M | 707.00M | 301.00M |
EBITDA | 9.23B | 7.89B | 6.52B | 4.88B | 3.10B | 2.17B | 920.00M |
EBITDA Ratio | 28.50% | 28.70% | 29.87% | 29.20% | 25.53% | 21.63% | 30.44% |
Operating Income | 7.01B | 5.93B | 4.80B | 3.70B | 2.22B | 1.47B | 619.00M |
Operating Income Ratio | 21.64% | 21.31% | 22.00% | 22.03% | 18.22% | 14.61% | 20.48% |
Total Other Income/Expenses | -99.00M | -50.00M | -15.00M | -63.00M | -178.00M | -60.00M | -23.00M |
Income Before Tax | 6.91B | 5.88B | 4.79B | 3.64B | 2.18B | 1.41B | 596.00M |
Income Before Tax Ratio | 21.33% | 21.13% | 21.94% | 21.68% | 17.91% | 14.01% | 19.72% |
Income Tax Expense | 2.28B | 1.60B | 1.53B | 1.16B | 650.00M | 400.00M | 205.00M |
Net Income | 4.61B | 4.27B | 3.25B | 2.48B | 1.53B | 1.01B | 390.00M |
Net Income Ratio | 14.23% | 15.34% | 14.88% | 14.76% | 12.57% | 10.04% | 12.91% |
EPS | 71.75 | 71.16 | 57.73 | 46.54 | 31.45 | 21.71 | 13.94 |
EPS Diluted | 69.94 | 67.68 | 54.06 | 43.48 | 29.98 | 21.70 | 13.94 |
Weighted Avg Shares Out | 64.21M | 59.97M | 56.24M | 53.20M | 48.58M | 46.52M | 27.98M |
Weighted Avg Shares Out (Dil) | 65.87M | 63.05M | 59.97M | 56.95M | 50.97M | 46.54M | 27.98M |
Source: https://incomestatements.info
Category: Stock Reports